Back
Windtree Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
53
WINT
Windtree Therapeutics
Last Price:
$1.02
Seasonality Move:
-6.37%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WINT is experiencing selling pressure, which indicates risk of future bearish movement.
Windtree Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.8 | Buy |
| 20-day SMA: | 0.66 | Buy |
| 50-day SMA: | 0.72 | Buy |
| 200-day SMA: | 13.57 | Sell |
| 8-day EMA: | 0.68 | Buy |
| 20-day EMA: | 0.38 | Buy |
| 50-day EMA: | 0.18 | Buy |
| 200-day EMA: | 0.05 | Buy |
Windtree Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 66.25 | Buy |
| Chaikin Money Flow: | -111441507 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.48 - 0.82) | Buy |
| Bollinger Bands (100): | (0.5 - 1.94) | Sell |
Windtree Therapeutics Technical Analysis
| Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Windtree Therapeutics Stock
Is Windtree Therapeutics Stock a Buy?
-
Windtree Therapeutics share price is 1.05 while WINT 8-day simple moving average is 0.80, which is a Buy signal.
-
The stock price of WINT is 1.05 while Windtree Therapeutics 20-day SMA is 0.66, which makes it a Buy.
-
Windtree Therapeutics 50-day simple moving average is 0.72 while WINT share price is 1.05, making it a Buy technically.
-
WINT stock price is 1.05 and Windtree Therapeutics 200-day simple moving average is 13.57, creating a Sell signal.
WINT Technical Analysis vs Fundamental Analysis
Buy
53
Windtree Therapeutics (WINT)
is a Buy
Is Windtree Therapeutics a Buy or a Sell?
-
Windtree Therapeutics stock is rated a BuyThe current Windtree Therapeutics [WINT] share price is $1.05. The Score for WINT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Windtree Therapeutics Stock Info
Market Cap:
3.8M
Price in USD:
1.05
Share Volume:
126.1M
Windtree Therapeutics 52-Week Range
52-Week High:
737.44
52-Week Low:
0.36
Buy
53
Windtree Therapeutics (WINT)
is a Buy
Windtree Therapeutics Share Price Forecast
-
What is the Windtree Therapeutics stock price today?The Windtree Therapeutics stock price is 1.05 USD today.
-
Will WINT stock go up or go down?Windtree Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Windtree Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Windtree Therapeutics is not overvalued.
Is Windtree Therapeutics Stock a Buy?
-
Windtree Therapeutics share price is 1.05 while WINT 8-day exponential moving average is 0.68, which is a Buy signal.
-
The stock price of WINT is 1.05 while Windtree Therapeutics 20-day EMA is 0.38, which makes it a Buy.
-
Windtree Therapeutics 50-day exponential moving average is 0.18 while WINT share price is 1.05, making it a Buy technically.
-
WINT stock price is 1.05 and Windtree Therapeutics 200-day simple moving average is 0.05, creating a Buy signal.
Fundamental Analysis of Windtree Therapeutics
Is Windtree Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $313.50 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Windtree Therapeutics
Should I short Windtree Therapeutics stock?
-
WINT Moving Average Covergence Divergence (MACD) indicator is 0.23, suggesting Windtree Therapeutics is a Buy
-
Windtree Therapeutics Relative Strength Index (RSI) is 66.25, which suggest Windtree Therapeutics is overbought
-
The Bollinger Bands (25) for Windtree Therapeutics is (0.48 - 0.82), which suggest Windtree Therapeutics is a Sell
-
The Bollinger Bands (100) for Windtree Therapeutics is (0.5 - 1.94), which suggest Windtree Therapeutics is a Sell
* Windtree Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.